LAUREN LATSHAW: Open Payments
NPI 1700560836 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 54 payments from 16 companies in 2025. Trend: 2023 $365 · 2024 $1,097 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $257 |
| Janssen Biotech, Inc. | 9 | $167 |
| PROGENICS PHARMACEUTICALS, INC. | 5 | $130 |
| UROGEN PHARMA, INC. | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| ABBVIE INC. | 3 | $79 |
| Astellas Pharma US Inc | 3 | $67 |
| Ferring Pharmaceuticals Inc. | 3 | $54 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
Products named: ERLEADA, GEMTESA, PYLARIFY, Nubeqa, ORGOVYX, LUPRON DEPOT, Xtandi, ADSTILADRIN.
Industry payments across AZ — which companies pay providers there.
